The Impact of New Guidelines for Glucose Tolerance Testing on Clinical Practice and Laboratory Services

Overview

Journal CMAJ

Date 2004 Oct 27

PMID 15505270

Citations 6

Authors

Andrew W Lyon

Erik T Larsen

Alun L Edwards

Affiliations

Soon will be listed here.

Citing Articles

Clinical presentation of newly diagnosed diabetes patients in a rural district hospital in Eastern Uganda.

Mayega R, Rutebemberwa E Afr Health Sci. 2019; 18(3):707-719.

PMID: 30603004 PMC: 6307025. DOI: 10.4314/ahs.v18i3.29.

Diabetes and pre-diabetes among persons aged 35 to 60 years in eastern Uganda: prevalence and associated factors.

Mayega R, Guwatudde D, Makumbi F, Nakwagala F, Peterson S, Tomson G PLoS One. 2013; 8(8):e72554.

PMID: 23967317 PMC: 3743823. DOI: 10.1371/journal.pone.0072554.

HbA1c for screening and diagnosis of diabetes mellitus.

Higgins T Endocrine. 2012; 43(2):266-73.

PMID: 22907625 DOI: 10.1007/s12020-012-9768-y.

Trends in laboratory testing for diabetes in Ontario, Canada 1995-2005: a population-based study.

Wilson S, Lipscombe L, Rosella L, Manuel D BMC Health Serv Res. 2009; 9:41.

PMID: 19250533 PMC: 2657133. DOI: 10.1186/1472-6963-9-41.

How to diagnose diabetes.

Sivagnanam G CMAJ. 2005; 172(5):615.

PMID: 15738473 PMC: 550614. DOI: 10.1503/cmaj.1041707.

References

Engelgau M, Narayan K, Vinicor F . Identifying the target population for primary prevention: the trade-offs. Diabetes Care. 2002; 25(11):2098-9. DOI: 10.2337/diacare.25.11.2098. View

Anand S, Razak F, Vuksan V, Gerstein H, Malmberg K, Yi Q . Diagnostic strategies to detect glucose intolerance in a multiethnic population. Diabetes Care. 2003; 26(2):290-6. DOI: 10.2337/diacare.26.2.290. View

Schousboe K, Henriksen J, Kyvik K, Sorensen T, Hyltoft Petersen P . Reproducibility of S-insulin and B-glucose responses in two identical oral glucose tolerance tests. Scand J Clin Lab Invest. 2003; 62(8):623-30. DOI: 10.1080/003655102764654358. View

Kernohan A, Perry C, Small M . Clinical impact of the new criteria for the diagnosis of diabetes mellitus. Clin Chem Lab Med. 2003; 41(9):1239-45. DOI: 10.1515/CCLM.2003.190. View

Ganda O, Day J, Soeldner J, Connon J, Gleason R . Reproducibility and comparative analysis of repeated intravenous and oral glucose tolerance tests. Diabetes. 1978; 27(7):715-25. DOI: 10.2337/diab.27.7.715. View

Ko G, Chan J, Woo J, Lau E, Yeung V, Chow C . The reproducibility and usefulness of the oral glucose tolerance test in screening for diabetes and other cardiovascular risk factors. Ann Clin Biochem. 1998; 35 ( Pt 1):62-7. DOI: 10.1177/000456329803500107. View

. Will new diagnostic criteria for diabetes mellitus change phenotype of patients with diabetes? Reanalysis of European epidemiological data. DECODE Study Group on behalf of the European Diabetes Epidemiology Study Group. BMJ. 1998; 317(7155):371-5. PMC: 28629. DOI: 10.1136/bmj.317.7155.371. View

Meltzer S, LEITER L, Daneman D, Gerstein H, Lau D, Ludwig S . 1998 clinical practice guidelines for the management of diabetes in Canada. Canadian Diabetes Association. CMAJ. 1998; 159 Suppl 8:S1-29. PMC: 1255890. View

Shaw J, de Courten M, Boyko E, Zimmet P . Impact of new diagnostic criteria for diabetes on different populations. Diabetes Care. 1999; 22(5):762-6. DOI: 10.2337/diacare.22.5.762. View

10.

Marshall K . The folly of population screening for type 2 diabetes. CMAJ. 1999; 160(11):1592-3. PMC: 1230366. View

11.

Gerstein H, Meltzer S . Preventive medicine in people at high risk for chronic disease: the value of identifying and treating diabetes. CMAJ. 1999; 160(11):1593-5; discussion 1595-6. PMC: 1230367. View

12.

Knowler W, Barrett-Connor E, Fowler S, Hamman R, Lachin J, Walker E . Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002; 346(6):393-403. PMC: 1370926. DOI: 10.1056/NEJMoa012512. View

13.

Young T, Mustard C . Undiagnosed diabetes: does it matter?. CMAJ. 2001; 164(1):24-8. PMC: 80628. View

14.

Tuomilehto J, Lindstrom J, Eriksson J, Valle T, Hamalainen H, Ilanne-Parikka P . Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001; 344(18):1343-50. DOI: 10.1056/NEJM200105033441801. View

15.

Jorgensen L, Stahl M, Brandslund I, Hyltoft Petersen P, Borch-Johnsen K, Olivarius N . Plasma glucose reference interval in a low-risk population. 2. Impact of the new WHO and ADA recommendations on the diagnosis of diabetes mellitus. Scand J Clin Lab Invest. 2001; 61(3):181-90. DOI: 10.1080/003655101300133621. View

16.

Stevens R, Kothari V, Adler A, Stratton I . The UKPDS risk engine: a model for the risk of coronary heart disease in Type II diabetes (UKPDS 56). Clin Sci (Lond). 2001; 101(6):671-9. View

17.

van Walraven C . Practice guidelines and practicing physicians-who's guiding whom?. Clin Chem. 2001; 48(1):9-10. View

18.

Stern M, Williams K, Haffner S . Identification of persons at high risk for type 2 diabetes mellitus: do we need the oral glucose tolerance test?. Ann Intern Med. 2002; 136(8):575-81. DOI: 10.7326/0003-4819-136-8-200204160-00006. View

19.

Saydah S, Byrd-Holt D, Harris M . Projected impact of implementing the results of the diabetes prevention program in the U.S. population. Diabetes Care. 2002; 25(11):1940-5. DOI: 10.2337/diacare.25.11.1940. View